Study on Rebamipide alleviates Aspirin-induced injury through inhibiting the expression of miR-877-5p in human gastric epithelial cells

Weiwei HAN,Luxuan TAN,Chao LI,Bangshun HE,Ye FAN,Zhenyu ZHANG

DOI: https://doi.org/10.3969/j.issn.1006-5709.2018.06.015

2018-01-01

Abstract:Objective To investigate whether Rebamipide plays a protective role on Aspirin-induced injury through inhibiting the expression of miR-877-5p in human gastric epithelial cells ( GES-1) . Methods Cultured GES-1 cells were divided into control group, Aspirin injured group and different concentrations (0. 25, 0. 5, 1. 0 mmol/L) Rebam-ipide plus Aspirin groups. The expression of miR-877-5p was detected by qRT-PCR. The Aspirin treated cells were transfected with miR-877-5p inhibitors. The combination of Rebamipide and Aspirin treated cells were transfected with miR-8877-5p mimics. Cell proliferation and apoptosis were detected by CCK-8 and flow cytometry. The targeted genes of miR-877-5p were predicted by miRNA target databases, the GO and KEGG pathway were analyzed by DAVID data-base. Results qRT-PCR showed that the expression of miR-877-5p in Aspirin group was the highest than others. The expressions of miR-877-5p in different concentrations (0. 25, 0. 5, 1. 0 mmol/L) of Rebamipide plus Aspirin groups were 4. 28 ± 0. 25, 2. 45 ± 0. 28 and 1. 47 ± 0. 17. The expression of miR-877-5p was gradually decreased with the in-crease of concentration of Rebamipide. The CCK-8 assay and flow cytometry showed that miR-877-5p mimics transfec-tion blocked proliferations and promoted apoptosis in combination of Rebamipide and Aspirin treated cells, while miR-877-5p inhibitors promoted proliferation and inhibited apoptosis in Aspirin treated cells. The pathways of miR-877-5p targeted genes were almost focused on cAMP signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, and so on. Conclusion Rebamipide alleviates Aspirin-induced injury through inhibiting the expression of miR-877-5p in human gastric epithelial cells.